Clinical and subclinical macrovascular disease as predictors of cognitive decline in older patients with type 2 diabetes: The Edinburgh type 2 diabetes study

Diabetes Care

Volumn 36, Issue 9, 2013, Pages 2779-2786

  Feinkohl, Insa ^a   Keller, Marketa ^a   Robertson, Christine M ^a   Morling, Joanne R ^a   Williamson, Rachel M ^b   Nee, Lisa D ^b   McLachlan, Stela ^a   Sattar, Naveed ^c   Welsh, Paul ^c   Reynolds, Rebecca M ^d   Russ, Tom C ^a,e   Deary, Ian J ^a,f   Strachan, Mark W J ^b   Price, Jackie F ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e National Health Service   (United Kingdom)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AGE; AGED; ANGINA PECTORIS; ANKLE BRACHIAL INDEX; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; DEMENTIA; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HEART INFARCTION; HEART STRESS; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LETTER NUMBER SEQUENCING; MACROVASCULAR DISEASE; MAJOR CLINICAL STUDY; MALE; MATRIX REASONING; MILL HILL VOCABULARY SCALE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SCOTTISH INDEX OF MULTIPLE DEPRIVATION; TRAIL MAKING TEST B; TRANSIENT ISCHEMIC ATTACK; VASCULAR DISEASE;

AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; COGNITION DISORDERS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STROKE;

EID: 84891752988     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-2241     Document Type: Article

References (40)

1. Salthouse TA. When does age-related cognitive decline begin? Neurobiol Aging 2009;30: 507-514
2. Gállego J, Martínez-Vila E. Asymptomatic cerebrovascular disease and systemic diagnosis in stroke, atherothrombosis as a disease of the vascular tree. Cerebrovasc Dis 2005;20(Suppl. 2): 1-10
3. Rafnsson SB, Deary IJ, Smith FB, Whiteman MC, Fowkes FGR. Cardiovascular diseases and decline in cognitive function in an elderly community population: the Edinburgh Artery Study. Psychosom Med 2007;69: 425-434
4. Singh-Manoux A, Britton AR, Marmot M. Vascular disease and cognitive function: evidence from the Whitehall II Study. J Am Geriatr Soc 2003;51: 1445-1450
5. Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetesdsystematic overview of prospective observational studies. Diabetologia 2005;48: 2460-2469
6. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006;5: 64-74
7. Golden SH. Emerging therapeutic approaches for the management of diabetes mellitus and macrovascular complications. Am J Cardiol 2011;108(Suppl.):59B-67B
8. Mankovsky BN, Ziegler D. Stroke in patients with diabetes mellitus. Diabetes Metab Res Rev 2004;20: 268-287
9. Rydén L, Standl E, Bartnik M, et al.; Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC); European Association for the Study of Diabetes (EASD). Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. Eur Heart J 2007;28: 88-136
10. Magnusson M, Melander O, Israelsson B, Grubb A, Groop L, Jovinge S. Elevated plasma levels of Nt-proBNP in patients with type 2 diabetes without overt cardiovascular disease. Diabetes Care 2004; 27: 1929-1935
11. Brohall G, Odén A, Fagerberg B. Carotid artery intima-media thickness in patients with type 2 diabetes mellitus and impaired glucose tolerance: a systematic review. Diabet Med 2006;23: 609-616
12. Potier L, Abi Khalil C, Mohammedi K, Roussel R. Use and utility of ankle brachial index in patients with diabetes. Eur J Vasc Endovasc Surg 2011;41: 110-116
13. Harron KL, Feltbower RG, McKinney PA, Bodansky HJ, Campbell FM, Parslow RC. Rising rates of all types of diabetes in south Asian and non-south Asian children and young people aged 0-29 years in West Yorkshire, U.K., 1991-2006. Diabetes Care 2011;34: 652-654
14. Gregg EW, Cheng YJ, Saydah S, et al. Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006: findings from the National Health Interview Survey. Diabetes Care 2012;35: 1252-1257
15. Price JF, Reynolds RM, Mitchell RJ, et al. The Edinburgh Type 2 Diabetes Study: study protocol. BMC Endocr Disord 2008;8: 18-27
16. Marioni RE, Strachan MWJ, Reynolds RM, et al. Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes 2010;59: 710-713
17. Leng GC, Fowkes FG. The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. J Clin Epidemiol 1992;45: 1101-1109
18. Ding J, Strachan MW, Reynolds RM, et al.; Edinburgh Type 2 Diabetes Study Investigators. Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes 2010;59: 2883-2889
19. O'Carroll RE, Gilleard CJ. Estimation of premorbid intelligence in dementia. Br J Clin Psychol 1986;25: 157-158
20. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67: 361-370
21. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12: 189-198
22. Lancu I, Olmer A. The minimental state examinationdan up-to-date review. Harefuah 2006;145:687-690, 701 [in Hebrew]
23. O'Connor DW, Pollitt PA, Hyde JB, et al. The reliability and validity of the Mini- Mental State in a British community survey. J Psychiatr Res 1989;23: 87-96
24. Petersen RC, Thomas RG, Grundman M, et al.; Alzheimer's Disease Cooperative Study Group. Vitamin E and donepezil for the treatment ofmild cognitive impairment. N Engl J Med 2005;352: 2379-2388
25. Deary IJ, Whalley LJ, Crawford Jr. An 'instantaneous' estimate of a lifetime's cognitive change [article online], 2004. Available from http://www.sciencedirect.com/ science/article/pii/S0160289603000679. Accessed 18 March 2013
26. Rafnsson SB, Deary IJ, Smith FB, et al. Cognitive decline and markers of inflammation and hemostasis: the Edinburgh Artery Study. J Am Geriatr Soc 2007;55: 700-707
27. Spearman C. 'General intelligence', objectively determined and measured. Am J Psychol 1904;15: 201-292
28. Pendlebury ST, Rothwell PM. Risk of recurrent stroke, other vascular events and dementia after transient ischaemic attack and stroke. Cerebrovasc Dis 2009;27 (Suppl. 3): 1-11
29. Haan MN, Shemanski L, Jagust WJ, Manolio TA, Kuller L. The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA 1999;282: 40-46
30. Reijmer YD, van den Berg E, de Bresser J, et al.; Utrecht Diabetic Encephalopathy Study Group. Accelerated cognitive decline in patients with type 2 diabetes: MRI correlates and risk factors. DiabetesMetab Res Rev 2011;27: 195-202
31. Bruce DG, Davis WA, Casey GP, et al. Predictors of cognitive decline in older individuals with diabetes. Diabetes Care 2008;31: 2103-2107
32. Xu D, Zou L, Xing Y, et al. Diagnostic value of ankle-brachial index in peripheral arterial disease: a meta-analysis. Can J Cardiol 2013;29: 492-498
33. Gunstad J, Poppas A, Smeal S, et al. Relation of brain natriuretic peptide levels to cognitive dysfunction in adults.55 years of age with cardiovascular disease. Am J Cardiol 2006;98: 538-540
34. Kerola T, Nieminen T, Hartikainen S, Sulkava R, Vuolteenaho O, Kettunen R. Btype natriuretic peptide as a predictor of declining cognitive function and dementiada cohort study of an elderly general population with a 5-year followup. Ann Med 2010;42: 207-215
35. Saleh C. Carotid artery intima media thickness: a predictor of cognitive impairment? Front Biosci (Elite Ed) 2010;2: 980-990
36. Wendell CR, Zonderman AB, Metter EJ, Najjar SS, Waldstein SR. Carotid intimal medial thickness predicts cognitive decline among adults without clinical vascular disease. Stroke 2009;40: 3180-3185
37. Knopman D, Boland LL, Mosley TH, et al.; Atherosclerosis Risk in Communities (ARIC) Study Investigators. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001;56: 42-48
38. Johnson W, Price JF, Rafnsson SB, Deary IJ, Fowkes FGR. Ankledbrachial index predicts level of, but not change in, cognitive function: the Edinburgh Artery Study at the 15-year follow-up. Vasc Med 2010;15: 91-97
39. Price JF, McDowell S, Whiteman MC, Deary IJ, Stewart MC, Fowkes FGR. Ankle brachial index as a predictor of cognitive impairment in the general population: ten-year follow-up of the Edinburgh Artery Study. J Am Geriatr Soc 2006;54: 763-769
40. Stern Y. Cognitive reserve. Neuropsychologia 2009;47: 2015-2028